Rogers (ROG)

148.34 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/22/21 *Est.)

Latest Headlines

Genentech Announces FDA Approval of Gavreto (pralsetinib) for People With Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancers December 1, 2020 3:15 PM - BizWire Genentech Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal Polyps December 1, 2020 11:34 AM - BizWire Roche receives FDA Emergency Use Authorization for new semi-quantitative test to measure the level of SARS-CoV-2 antibodies December 1, 2020 11:30 AM - PR NewsWire Form 4 ROGERS CORP For: Nov 25 Filed by: Wallace Peter C November 30, 2020 11:48 AM - SEC Filing Genentech Announces FDA Approval of Xofluza for the Prevention of Influenza Following Contact With an Infected Person November 23, 2020 2:46 PM - BizWire Rogers Corp (ROG) PT Raised to $178 at Stifel on Positive Asia Checks November 23, 2020 7:52 AM - StreetInsider OneOncology Partners with Genentech to Bring Personalized Cancer Research to Patients at Community Oncology Sites November 23, 2020 6:15 AM - PR NewsWire Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP) November 17, 2020 8:00 AM - PR NewsWire Form 4 ROGERS CORP For: Nov 09 Filed by: Wallace Peter C November 10, 2020 3:13 PM - SEC Filing Form 4 ROGERS CORP For: Nov 05 Filed by: Knoll Jay B November 6, 2020 11:52 AM - SEC Filing Genentech to Present New Data Across 16 Blood Disorders at the American Society of Hematology 2020 Annual Meeting November 5, 2020 9:00 AM - BizWire Exclusive: WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir November 5, 2020 7:59 AM - StreetInsider Form 4 ROGERS CORP For: Nov 02 Filed by: BUCKLEY BENJAMIN MCNEIL November 3, 2020 12:48 PM - SEC Filing Form 10-Q ROGERS CORP For: Sep 30 October 30, 2020 3:54 PM - SEC Filing Rogers Corp (ROG) PT Raised to $160 at B.Riley/FBR October 30, 2020 8:28 AM - StreetInsider Rogers (ROG) Tops Q3 EPS by 45c, Revenues Beat; Offers 4Q EPS Guidance Above Consensus October 29, 2020 4:57 PM - StreetInsider Form 8-K ROGERS CORP For: Oct 29 October 29, 2020 4:11 PM - SEC Filing Rogers Corporation Reports Third Quarter 2020 Results October 29, 2020 4:09 PM - BizWire Roche receives FDA approval for the cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with non-small cell lung cancer October 29, 2020 12:45 PM - PR NewsWire Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19 October 22, 2020 1:00 AM - Globe NewsWire Rogers Schedules Q3 2020 Earnings Call for October 29, 2020 October 20, 2020 3:39 PM - BizWire Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia October 16, 2020 7:30 PM - BizWire Form 8-K ROGERS CORP For: Oct 16 October 16, 2020 3:45 PM - SEC Filing Roche sees problems from warehouse glitch in Britain 'cleared out' by weekend October 15, 2020 9:40 AM - StreetInsider European shares sink on lockdown concerns as virus cases surge October 15, 2020 3:19 AM - StreetInsider Roche Selects Veeva Development Cloud Applications October 12, 2020 7:03 AM - BizWire Roche Selects Veeva Development Cloud Applications October 12, 2020 7:03 AM - BizWire UK's COVID testing system hit by Roche supply chain glitch October 7, 2020 4:32 AM - StreetInsider Regeneron says its COVID-19 treatment reduces viral levels, improves symptoms September 29, 2020 4:12 PM - StreetInsider Companies with NDRs 09/29 September 29, 2020 7:18 AM - StreetInsider Genentech Presents New 2-Year Data for Evrysdi (risdiplam) in Infants With Type 1 Spinal Muscular Atrophy (SMA) September 28, 2020 1:00 AM - BizWire Roche Alzheimer's drug fails, joining long list of trial flops September 23, 2020 9:21 AM - StreetInsider Travel rebound, Adidas support European stocks despite mixed data September 23, 2020 3:26 AM - StreetInsider Inflazome Announces Acquisition by Roche September 21, 2020 2:00 AM - BizWire Genentech Presents New Data From Multiple Phase III Studies of Tecentriq in Triple-Negative Breast Cancer at ESMO Virtual Congress 2020 September 19, 2020 10:20 AM - BizWire Form 4 ROGERS CORP For: Sep 17 Filed by: LUDWIG MICHAEL M September 18, 2020 3:53 PM - SEC Filing Roche rises on word of COVID trial win, new test and European cancer drug nod September 18, 2020 12:29 PM - StreetInsider Genentech’s Phase III EMPACTA Study Showed Actemra Reduced the Likelihood of Needing Mechanical Ventilation in Hospitalized Patients With COVID-19 Associated Pneumonia September 18, 2020 1:00 AM - BizWire U.S. plans for hundreds of millions of cheap, fast COVID-19 tests September 17, 2020 7:04 AM - StreetInsider European healthcare stocks hit by Trump drug order September 14, 2020 5:07 AM - StreetInsider New Data Further Reinforce Genentech’s Ocrevus (ocrelizumab) as a Highly Effective Treatment for People With Multiple Sclerosis September 11, 2020 1:00 AM - BizWire New Data Show Genentech’s Enspryng Significantly Reduces Severity and Risk of Relapse in Neuromyelitis Optica Spectrum Disorder September 10, 2020 1:00 AM - BizWire Genentech Expands Its Multiple Sclerosis Portfolio With Investigational BTK Inhibitor Fenebrutinib and Initiates Novel Clinical Trials for Ocrevus (ocrelizumab) September 9, 2020 1:00 AM - BizWire Genentech Announces FDA Approval of Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer September 4, 2020 7:00 PM - BizWire Full Article List